Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 16 clinical trials
Beta-blockers to Patients With Chronic Obstructive Pulmonary Disease

. Exclusion criteria include hypersensitivity against metoprolol, atrioventricular (AV) block II or II or sick sinus syndrome without pacemaker, atrial fibrillation or flutter, clinical signs of or previously

bronchodilator
copd exacerbation
pulmonary function test
spirometry
respiratory symptom
  • 37 views
  • 18 May, 2022
  • 1 location
Preemptive Pharmacogenetic-guided Metoprolol Management for PostoperativeAtrial Fibrillation in Cardiac Surgery

Metoprolol is frequently administered to cardiac surgery patients to reduce the incidence of postoperative atrial fibrillation (PoAF). Metoprolol is metabolized by the enzyme CYP2D6, which is

  • 0 views
  • 21 Mar, 2021
  • 1 location
Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy

In this trial, the investigators will assess the effect of metoprolol in patients with hypertrophic cardiomyopathy who underwent alcohol septal ablation. The investigators will evaluate the

septal ablation
heart failure
metoprolol
hypertrophy
  • 69 views
  • 23 Mar, 2022
  • 1 location
The Effects of Nebivolol on Aortic Impedance Parameters in Type 2 Diabetes (The Effort Trial)

To examine changes in aortic impedance in patients on nebivolol vs. metoprolol succinate in Type 2 hypertensive diabetic patients as measured by the change from baseline in central

nebivolol
diabetes
metoprolol
systolic blood pressure
  • 36 views
  • 08 Nov, 2020
  • 1 location
Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

like Metoprolol or even sometimes Esmolol. Landiolol is already approved for the treatment of atrial tachycardias but is not yet approved for the use of prevention of POAF. In multiple previous

arrhythmia
Accepts healthy volunteers
fibrillation
beta blockers
  • 0 views
  • 31 Oct, 2021
  • 1 location
Effects of Triiodothyronine (T3) in Ischemic Heart Failure

This study aims to determine whether giving triiodothyronine (T3), a thyroid hormone, is safe and helps improve symptoms and signs of heart failure. The study is divided into 2 phases. In the first phase, participants have a 50-50 chance of receiving the study drug. Participants who are randomized to receive …

ejection fraction
metoprolol
beta blockers
cardiac resynchronization therapy
heart failure
  • 0 views
  • 12 Jul, 2022
  • 2 locations
Low-dose Quadruple Combination Therapy in Patients With Hypertension (QUADUAL)

This study aims to compare the antihypertensive effect of initial treatment with a single capsule containing quadruple combination of half-dose of blood pressure medicines or standard dose dual combination in patients with hypertension.

hypertension
amlodipine
metoprolol
antihypertensive drugs
blood pressure diastolic
  • 0 views
  • 24 Jul, 2022
  • 1 location
Race, Natriuretic Peptides and Physiological Perturbations

The purpose of the study is to understand the origins of differential response to beta-blockers in African-Americans and may provide insight regarding racial differences in cardiovascular risk.

Accepts healthy volunteers
  • 3 views
  • 25 Feb, 2022
  • 1 location
Ultra-high-resolution CT vs. Conventional Angiography for Detecting Coronary Heart Disease

Cardiac catheterization with invasive coronary angiography is the gold standard for determining the presence or absence of significant coronary heart disease (CHD). However, cardiac catheterization is costly and, as an invasive procedure, it is associated with some risk of adverse events, rarely even stroke, myocardial infarction, or death. Recent advances …

myocardial infarction
angiography
revascularisation
computed tomography angiography
stenosis
  • 2 views
  • 23 Jul, 2022
  • 1 location
Post-Acute Sequelae of Coronavirus-19 (COVID-19) With Dyspnea on Exertion And Associated TaChycardia TrEatment Study (PEACE)

Most patients with acute COVID-19 (Coronavirus 19) recover within weeks, however a significant number of individuals will develop the post-acute COVID 19 syndrome (PASC). As of July 2021, the post COVID syndrome qualifies as a disability under the Americans with Disabilities Act. The symptoms which comprise this condition are highly …

ejection fraction
beta blockers
  • 22 views
  • 14 Apr, 2022